Wonbiogen Co., Ltd. (KOSDAQ:307280)

Wonbiogen Revenue

Wonbiogen had revenue of 9.28B KRW in the quarter ending March 31, 2026, with 12.43% growth. This brings the company's revenue in the last twelve months to 36.27B, up 14.69% year-over-year. In the year 2025, Wonbiogen had annual revenue of 35.24B with 15.78% growth.

• Revenue (ttm): 36.27B
• Revenue Growth: +14.69%
• P/S Ratio: 1.13
• Revenue / Employee: 459.11M
• Employees: 79
• Market Cap: 40.85B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	35.24B	4.80B	15.78%
Dec 31, 2024	30.44B	824.93M	2.79%
Dec 31, 2023	29.61B	2.87B	10.72%
Dec 31, 2022	26.75B	9.03B	50.94%
Dec 31, 2021	17.72B	5.70B	47.46%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 4, 2026

Data Sources Report a data error